APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Zoster Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Zoster Vaccine Industry Growth and Trends Forecast to 2032

Report ID 174048950120 December 202596 pages

Choose your research edition.

Industry ResearchZoster Vaccine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Zoster Vaccine Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Zoster Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Zoster Vaccine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Zoster Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Zoster Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Zoster Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Zoster Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Zoster Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Zoster Vaccine include GSK, Merck, SK chemicals, Sanofi Pasteur and Green Cross Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Zoster Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Zoster Vaccine market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Zoster Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Zoster Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Zoster Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Zoster Vaccine Market by Company

GSK

Merck

SK chemicals

Sanofi Pasteur

Green Cross Corp

Zoster Vaccine Segment by Type

Live Attenuated Vaccine

Recombinant

Zoster Vaccine Segment by Application

Government Institution

Private Sector

Other

Zoster Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zoster Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Zoster Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zoster Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Zoster Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Zoster Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Live Attenuated Vaccine Table 2. Major Company of Recombinant Table 3. Global Zoster Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Zoster Vaccine Sales by Type (2021-2026) & (W Units) Table 5. Global Zoster Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Zoster Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Zoster Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Zoster Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Zoster Vaccine Sales by Type (2027-2032) & (W Units) Table 10. Global Zoster Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Zoster Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Zoster Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Zoster Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Zoster Vaccine Sales by Type (2021-2026) & (W Units) Table 15. North America Zoster Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Zoster Vaccine Sales by Type (2021-2026) & (W Units) Table 17. Europe Zoster Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Zoster Vaccine Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Zoster Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Zoster Vaccine Sales by Type (2021-2026) & (W Units) Table 21. Latin America Zoster Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Zoster Vaccine Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Zoster Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Zoster Vaccine Industry Trends Table 25. Zoster Vaccine Industry Drivers Table 26. Zoster Vaccine Industry Opportunities and Challenges Table 27. Zoster Vaccine Industry Restraints Table 28. Global Zoster Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Zoster Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Zoster Vaccine Sales by Company (2021-2026) & (W Units) Table 31. Global Zoster Vaccine Sales Share by Company (2021-2026) Table 32. Global Zoster Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Zoster Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Zoster Vaccine Major Company Production Sites and Headquarters Table 35. Global Zoster Vaccine Company, Product Type & Application Table 36. Global Zoster Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Zoster Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Zoster Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Zoster Vaccine Sales by Region (2021-2026) & (W Units) Table 41. Global Zoster Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Zoster Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Zoster Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Zoster Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Zoster Vaccine Sales by Region (2027-2032) & (W Units) Table 46. Global Zoster Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Zoster Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Zoster Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Zoster Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Zoster Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Zoster Vaccine Sales by Application (2021-2026) & (W Units) Table 52. Global Zoster Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Zoster Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Zoster Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Zoster Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Zoster Vaccine Sales by Application (2027-2032) & (W Units) Table 57. Global Zoster Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Zoster Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Zoster Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Zoster Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Zoster Vaccine Sales by Application (2021-2026) & (W Units) Table 62. North America Zoster Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Zoster Vaccine Sales by Application (2021-2026) & (W Units) Table 64. Europe Zoster Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Zoster Vaccine Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Zoster Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Zoster Vaccine Sales by Application (2021-2026) & (W Units) Table 68. Latin America Zoster Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Zoster Vaccine Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Zoster Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. GSK Company Information Table 72. GSK Business Overview Table 73. GSK Zoster Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. GSK Zoster Vaccine Product Portfolio Table 75. GSK Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Zoster Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Merck Zoster Vaccine Product Portfolio Table 80. Merck Recent Development Table 81. SK chemicals Company Information Table 82. SK chemicals Business Overview Table 83. SK chemicals Zoster Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. SK chemicals Zoster Vaccine Product Portfolio Table 85. SK chemicals Recent Development Table 86. Sanofi Pasteur Company Information Table 87. Sanofi Pasteur Business Overview Table 88. Sanofi Pasteur Zoster Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Sanofi Pasteur Zoster Vaccine Product Portfolio Table 90. Sanofi Pasteur Recent Development Table 91. Green Cross Corp Company Information Table 92. Green Cross Corp Business Overview Table 93. Green Cross Corp Zoster Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Green Cross Corp Zoster Vaccine Product Portfolio Table 95. Green Cross Corp Recent Development Table 96. North America Zoster Vaccine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 97. North America Zoster Vaccine Sales by Country (2021-2026) & (W Units) Table 98. North America Zoster Vaccine Sales Market Share by Country (2021-2026) Table 99. North America Zoster Vaccine Sales Forecast by Country (2027-2032) & (W Units) Table 100. North America Zoster Vaccine Sales Market Share Forecast by Country (2027-2032) Table 101. North America Zoster Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Zoster Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Zoster Vaccine Market Share by Country (2021-2026) Table 104. North America Zoster Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Zoster Vaccine Market Share Forecast by Country (2027-2032) Table 106. Europe Zoster Vaccine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 107. Europe Zoster Vaccine Sales by Country (2021-2026) & (W Units) Table 108. Europe Zoster Vaccine Sales Market Share by Country (2021-2026) Table 109. Europe Zoster Vaccine Sales Forecast by Country (2027-2032) & (W Units) Table 110. Europe Zoster Vaccine Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Zoster Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Zoster Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Zoster Vaccine Market Share by Country (2021-2026) Table 114. Europe Zoster Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Zoster Vaccine Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Zoster Vaccine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Zoster Vaccine Sales by Country (2021-2026) & (W Units) Table 118. Asia-Pacific Zoster Vaccine Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Zoster Vaccine Sales Forecast by Country (2027-2032) & (W Units) Table 120. Asia-Pacific Zoster Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Zoster Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Zoster Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Zoster Vaccine Market Share by Country (2021-2026) Table 124. Asia-Pacific Zoster Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Zoster Vaccine Market Share Forecast by Country (2027-2032) Table 126. Latin America Zoster Vaccine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 127. Latin America Zoster Vaccine Sales by Country (2021-2026) & (W Units) Table 128. Latin America Zoster Vaccine Sales Market Share by Country (2021-2026) Table 129. Latin America Zoster Vaccine Sales Forecast by Country (2027-2032) & (W Units) Table 130. Latin America Zoster Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Zoster Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Zoster Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Zoster Vaccine Market Share by Country (2021-2026) Table 134. Latin America Zoster Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Zoster Vaccine Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Zoster Vaccine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Zoster Vaccine Sales by Country (2021-2026) & (W Units) Table 138. Middle East and Africa Zoster Vaccine Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Zoster Vaccine Sales Forecast by Country (2027-2032) & (W Units) Table 140. Middle East and Africa Zoster Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Zoster Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Zoster Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Zoster Vaccine Market Share by Country (2021-2026) Table 144. Middle East and Africa Zoster Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Zoster Vaccine Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Zoster Vaccine Distributors List Table 149. Zoster Vaccine Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Zoster Vaccine Image Figure 2. Global Zoster Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Zoster Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Zoster Vaccine Sales (2021-2032) & (W Units) Figure 5. Live Attenuated Vaccine Image Figure 6. Global Live Attenuated Vaccine Sales YoY Growth (2021-2032) & (W Units) Figure 7. Recombinant Image Figure 8. Global Recombinant Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Zoster Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Zoster Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Zoster Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Zoster Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Zoster Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Zoster Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Zoster Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Zoster Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Zoster Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Zoster Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Zoster Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Zoster Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Zoster Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Government Institution Image Figure 24. Global Government Institution Sales YoY Growth (2021-2032) & (W Units) Figure 25. Private Sector Image Figure 26. Global Private Sector Sales YoY Growth (2021-2032) & (W Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Zoster Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Zoster Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Zoster Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Zoster Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Zoster Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Zoster Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Zoster Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Zoster Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Zoster Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Zoster Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Zoster Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Zoster Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Zoster Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Zoster Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Zoster Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Zoster Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Zoster Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Zoster Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Zoster Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Zoster Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Zoster Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Zoster Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Zoster Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Zoster Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Zoster Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Zoster Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Zoster Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Zoster Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Zoster Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Zoster Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Zoster Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Zoster Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Zoster Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Zoster Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Live Attenuated Vaccine
  • Recombinant
Applications
  • Government Institution
  • Private Sector
  • Other
Companies covered
  • GSK
  • Merck
  • SK chemicals
  • Sanofi Pasteur
  • Green Cross Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Zoster Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Zoster Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Zoster Vaccine Market by Type
  6. 1.3.1 Live Attenuated Vaccine
  7. 1.3.2 Recombinant
  8. 1.4 Global Zoster Vaccine Market Size by Type
  9. 1.4.1 Global Zoster Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Zoster Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Zoster Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Zoster Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Zoster Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Zoster Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Zoster Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Zoster Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Zoster Vaccine Industry Trends
  2. 2.2 Zoster Vaccine Industry Drivers
  3. 2.3 Zoster Vaccine Industry Opportunities and Challenges
  4. 2.4 Zoster Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Zoster Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Zoster Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Zoster Vaccine Price (2021-2026)
  4. 3.4 Global Zoster Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Zoster Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Zoster Vaccine Company, Product Type & Application
  7. 3.7 Global Zoster Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Zoster Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Zoster Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Zoster Vaccine Tier 1, Tier 2, and Tier 3
4 Zoster Vaccine Regional Status and Outlook
  1. 4.1 Global Zoster Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Zoster Vaccine Historic Market Size by Region
  3. 4.2.1 Global Zoster Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Zoster Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Zoster Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Zoster Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Zoster Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Zoster Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Zoster Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Zoster Vaccine by Application
  1. 5.1 Zoster Vaccine Market by Application
  2. 5.1.1 Government Institution
  3. 5.1.2 Private Sector
  4. 5.1.3 Other
  5. 5.2 Global Zoster Vaccine Market Size by Application
  6. 5.2.1 Global Zoster Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Zoster Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Zoster Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Zoster Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Zoster Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Zoster Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Zoster Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Zoster Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Zoster Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Zoster Vaccine Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Zoster Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Zoster Vaccine Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 SK chemicals
  14. 6.3.1 SK chemicals Company Information
  15. 6.3.2 SK chemicals Business Overview
  16. 6.3.3 SK chemicals Zoster Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 SK chemicals Zoster Vaccine Product Portfolio
  18. 6.3.5 SK chemicals Recent Developments
  19. 6.4 Sanofi Pasteur
  20. 6.4.1 Sanofi Pasteur Company Information
  21. 6.4.2 Sanofi Pasteur Business Overview
  22. 6.4.3 Sanofi Pasteur Zoster Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Pasteur Zoster Vaccine Product Portfolio
  24. 6.4.5 Sanofi Pasteur Recent Developments
  25. 6.5 Green Cross Corp
  26. 6.5.1 Green Cross Corp Company Information
  27. 6.5.2 Green Cross Corp Business Overview
  28. 6.5.3 Green Cross Corp Zoster Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Green Cross Corp Zoster Vaccine Product Portfolio
  30. 6.5.5 Green Cross Corp Recent Developments
7 North America by Country
  1. 7.1 North America Zoster Vaccine Sales by Country
  2. 7.1.1 North America Zoster Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Zoster Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Zoster Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Zoster Vaccine Market Size by Country
  6. 7.2.1 North America Zoster Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Zoster Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Zoster Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Zoster Vaccine Sales by Country
  2. 8.1.1 Europe Zoster Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Zoster Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Zoster Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Zoster Vaccine Market Size by Country
  6. 8.2.1 Europe Zoster Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Zoster Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Zoster Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Zoster Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Zoster Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Zoster Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Zoster Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Zoster Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Zoster Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Zoster Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Zoster Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Zoster Vaccine Sales by Country
  2. 10.1.1 South America Zoster Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Zoster Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Zoster Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Zoster Vaccine Market Size by Country
  6. 10.2.1 South America Zoster Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Zoster Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Zoster Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Zoster Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Zoster Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Zoster Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Zoster Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Zoster Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Zoster Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Zoster Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Zoster Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Zoster Vaccine Value Chain Analysis
  2. 12.1.1 Zoster Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Zoster Vaccine Production Mode & Process
  7. 12.2 Zoster Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Zoster Vaccine Distributors
  10. 12.2.3 Zoster Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst